PRECIPIO, INC. Convertible Debt, Current
PRECIPIO, INC. (PRPO) had Convertible Debt, Current of $3.13 million as of 2019-03-31, per its 10-Q filed 2019-05-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:ConvertibleDebtCurrent · last filed 2019-05-16
- 2019-03-31: Convertible Debt, Current $3.13M.
- 2018-12-31: Convertible Debt, Current $4.38M.
- 2018-09-30: Convertible Debt, Current $256.00K.
- 2018-06-30: Convertible Debt, Current $9.00K.
| Period end | Convertible Debt, Current |
|---|---|
| 2019-03-31 | $3.13M 10-Q · filed 2019-05-16 |
| 2018-12-31 | $4.38M 10-Q · filed 2019-05-16 |
| 2018-09-30 | $256.00K 10-Q · filed 2018-11-19 |
| 2018-06-30 | $9.00K 10-Q · filed 2018-08-16 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-20 |
| 2017-06-30 | $166.00K 10-Q · filed 2017-08-22 |
| 2016-12-31 | $695.00K 10-K · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |